Cancer Drug Fund didn’t deliver value ‘to patients or society’: A fund that spent more than £1 billion on expensive
Cancer Drug Fund didn’t deliver value ‘to patients or society’: A fund that spent more than £1 billion on expensive new cancer drugs in England had little clinical benefit, a study of 29 medicines has concluded
Source: newscientist.com
U.S. cancer doctors drop pricey drugs with little or no effect: U.S. oncologists, aware that patients are paying more of
U.S. cancer doctors drop pricey drugs with little or no effect: U.S. oncologists, aware that patients are paying more of the costs of expensive cancer drugs, are increasingly declining to prescribe medicines that have scant or no effect, even as a last resort.
Source: reuters.com
Call for Britain to over-ride patents on Roche cancer drug: A group of patients and campaigners has called on Britain's
Call for Britain to over-ride patents on Roche cancer drug: A group of patients and campaigners has called on Britain's health minister to over-ride patents protecting Roche's expensive breast cancer drug Kadcyla to allow for the import or manufacture of cut-price copies.
Source: reuters.com
Exclusive: Americans overpaying hugely for cancer drugs - study
Exclusive: Americans overpaying hugely for cancer drugs - study
Source: reuters.com
RSS feed